The Onchocerciasis Vaccine for Africa-TOVA-Initiative.

Authors

Peter J Hotez, Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development, National School of Tropical Medicine, Baylor College of MedicineFollow
Maria Elena Bottazzi, Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development, National School of Tropical Medicine, Baylor College of MedicineFollow
Bin Zhan, Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development, National School of Tropical Medicine, Baylor College of MedicineFollow
Benjamin L Makepeace, Institute of Infection and Global Health, University of Liverpool
Thomas R Klei, Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State UniversityFollow
David Abraham, Department of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson UniversityFollow
David W Taylor, Division of Pathway Medicine, School for Biomedical Studies, University of Edinburgh
Sara Lustigman, Laboratory of Molecular Parasitology, Lindsley F Kimball Research Institute, New York Blood CenterFollow

Document Type

Article

Publication Date

1-29-2015

Comments

This article has been peer reviewed. It was published in: PLoS Neglected Tropical Diseases.

Volume 9, Issue 1, 2015, 5p.

The published version is available at DOI: 10.1371/journal.pntd.0003422

Copyright © © 2015 Hotez et al.

Recommended Citation

Hotez, Peter J; Bottazzi, Maria Elena; Zhan, Bin; Makepeace, Benjamin L; Klei, Thomas R; Abraham, David; Taylor, David W; and Lustigman, Sara, "The Onchocerciasis Vaccine for Africa-TOVA-Initiative." (2015). Department of Microbiology and Immunology Faculty Papers. Paper 72.
https://jdc.jefferson.edu/mifp/72

PubMed ID

25634641